A brief look back at our first on site GA Meeting from 23rd to 25th January 2023 in Sonthofen (Germany). In this gathering, the SATURN3 partners came together to network, to align goals and to further shapen the future direction of SATURN3.
Author: Tassilo Steinmann
SATURN General Assembyl Meeting 2024 – Looking Back
From 29th to 30th January 2024, the SATURN3 team gathered in Mainz (Germany). This annual retreat provided an important platform for strategic updates and collaboration among all SATURN3 members.
SATURN3 early-career researchers selected for the “Rising Stars” Event of the German Federal Ministry for Education, Research, Technology and Space
On 28 October 2025, we (Saturn3 PhD candidate Abir Hussein from Regensburg, postdoctoral researcher Lennart Versemann from Göttingen, surgical resident Karl Knipper from Cologne, and postdoctoral researcher and scientific project coordinator of Saturn3 Vivien Ullrich from Essen), had the exceptional opportunity to participate as one of only 40 selected early-career researchers from across Germany in… Continue reading SATURN3 early-career researchers selected for the “Rising Stars” Event of the German Federal Ministry for Education, Research, Technology and Space
Therapy resistance, recurrence and metastasis: How can resistance be overcome?
An interview with Saturn3 Co-coordinator Prof. Dr. Andreas Trumpp (German Cancer Research Center (DKFZ), Head of Department “Stem Cells and Cancer”, Managing Director of the Stem Cell Institute “HI-STEM gGmbH”) Published in the February 2025 edition of the breast cancer magazine Mamma Mia!: https://mammamia-online.de/shop/brustkrebsmagazin-digital-02-2025 You’re also welcome to take a look at the free guide… Continue reading Therapy resistance, recurrence and metastasis: How can resistance be overcome?
Multimodal survival prediction in advanced pancreatic cancer using machine learning
Keyl J, Kasper S, Wiesweg M, et al. Multimodal survival prediction in advanced pancreatic cancer using machine learning (PMID: 35988455). ESMO Open. Epub 2022.
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma
Heid I, Münch C, Karakaya S, et al. Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma (PMID: 36494842). Cancer Metab. 2022.
HAPLN1 potentiates peritoneal metastasis in pancreatic cancer
Wiedmann L, De Angelis Rigotti F, Vaquero-Siguero N, et al. HAPLN1 potentiates peritoneal metastasis in pancreatic cancer (PMID: 37095087). Nat Commun. 2023.
Enhancing sensitivity and versatility of Tn5-based single cell omics
Seufert I, Sant P, Bauer K, et al. Enhancing sensitivity and versatility of Tn5-based single cell omics. bioRxiv. 2023.
Approaches for single-cell RNA sequencing across tissues and cell types
Sant P, Rippe K and Mallm JP. Approaches for single-cell RNA sequencing across tissues and cell types (PMID: 37062951). Transcription. 2023.
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer
Saini M, Schmidleitner L, Moreno HD, et al. Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer (PMID: 37257449). Cell Rep. Epub 2023.
